Showing posts with label Original Antigenic Sin. Show all posts
Showing posts with label Original Antigenic Sin. Show all posts

Thursday, August 29, 2013

Branswell: Universal Flu Vaccines & The `Canadian Problem’

image

 

 

# 7613

 

The most intriguing read of the morning, by far, is Helen Branswell’s long report that looks at a study that raises some red flags on the prospects of creating the Holy Grail of immunology; the Universal Flu Vaccine.

 

The problem, which we’ve discussed before, has recently been dubbed VAERD – or Vaccine Associated Enhanced Respiratory Disease.

Since no one covers these issues better than Helen, I’ll step aside and invite you to read her entire article, after which I’ll be back with a little more.

 

Study raises red flag for universal flu vaccine

By: Helen Branswell The Canadian Press, Published on Wed Aug 28 2013

Phenomenon, known as the “Canadian problem,” sees vaccination against one strain of flu actually seems to raise the risk of severe infection after exposure to a related but different strain

 

It is worth noting that 4 years ago, Helen Branswell, was among the first to report on the so-called `Canadian Problem’ (see Branswell On The Canadian Flu Shot Controversy).

 

 

First stop, the link to the study and abstract, which appears in the Journal Science Translational Medicine:

 

Sci Transl Med 28 August 2013:
Vol. 5, Issue 200, p. 200ra114
Sci. Transl. Med. DOI: 10.1126/scitranslmed.3006366

Research Article

Influenza

Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease

Surender Khurana, Crystal L. Loving, Jody Manischewitz, Lisa R. King, Phillip C. Gauger, Jamie Henningson, Amy L. Vincent, and Hana Golding

 

For those looking for more can examine contributing author Phillip C. Gauger’s 2012 186-page PhD dissertation - Characterization of vaccine-associated enhanced respiratory disease (VAERD) in swine administered an inactivated δ-cluster influenza vaccine and challenged with pandemic A/H1N1 virus - which is available from Iowa State University’s Digital Repository.  

 

We’ve looked at other research studies in the past which dealt with related issues of OAS (Original Antigenic Sin) and ADE (Antigenic Dependent Enhancement), which you may wish to revisit. 

 

Eurosurveillance: H7N9 Virus-Host Interactions & Age Shift

EID Journal: Revisiting The `Canadian Problem’

 

Last September, in ICAAC: Ferreting Out The `Canadian Problem’, we saw an interview with Dr. Danuta Skowronski, who was involved in the original Canadian studies, and who had recently duplicated the vaccine effect using ferrets in a double-blind study.

 

How VAERD and OAS and ADE all tie together, and their implications for the creation of a universal flu vaccine remains poorly understood.

 

What we are learning is that the human immune response is far more complex than we ever imagined and the constantly-changing antigenic face of influenza adds an even greater layer of complexity.

 

While the development of a `universal flu vaccine’ is a laudable (and hopefully, obtainable) goal – given the limits of our current understanding of our own immune system – a degree of caution remains warranted as research moves forward.

Friday, April 26, 2013

Eurosurveillance: H7N9 Virus-Host Interactions & Age Shift

image

H7N9 Age Curve - Credit CIDRAP 

 

 

# 7194

 

One of the ongoing mysteries surrounding the H7N9 outbreak in China is the disproportionate skewing of known cases towards elderly males – even though all ages in the community are assumed to be equally immunologically naive to this emerging virus.

 

This excellent chart by Laidback Al clearly shows the disproportionate impact H7N9 is having on the elderly, while the largest segment of the Chinese population –  middle-aged adults - are far less represented in the case counts.

 

image

 

Source FluTrackers Demographic and Geographic Overview of H7N9

For some additional discussion on this unusual patterning of cases, you may wish to revisit H7N9: The Riddle Of The Ages and last Monday’s WHO H7N9 Study: Preliminary Age & Sex Distribution.

 

While many epidemiologists are investigating exposure differences to poultry or other birds that might explain this age/sex shift, researchers from Canada are exploring a different scenario.


One that harkens back to a mystery still unresolved from the 2009 pandemic – the observation (particularly in Canada) that people who received the 2008 flu shot seemed to be more susceptible to catching the H1N1 pandemic strain the following spring.


The so-called `Canadian Problem’.

 

Fair warning, this letter from the Eurosurveillance  Journal offers up a hypothesis based on an extremely complex and poorly understood phenomenon. 

 

None of what follows is exactly `light’ reading.

 

Rather than mangle the author’s words by excerpting portions here, I would invite you to follow the link and read it in its entirety.

 

After you return, I’ll take a stab at trying to make it easier to understand (wish me luck).

 

Eurosurveillance, Volume 18, Issue 17, 25 April 2013

Letters

Virus-host interactions and the unusual age and sex distribution of human cases of influenza A(H7N9) in China, April 2013

D M Skowronski, N Z Janjua, T L Kwindt, G De Serres

 

What follows is a layman’s explanation of some poorly understood areas of our immune system. Real scientists may want to avert their eyes. 

 

Normally, after you’ve been infected by most viruses, you develop neutralizing antibodies that can recognize that pathogen and protect you from being infected again. Variances in individual immune systems and time since exposure can weaken these defenses.

 

But this is the reason why influenza viruses must continually mutate, else they’d run out of susceptible hosts.

 

But sometimes, the system doesn’t work as designed.

 

Sometimes - and for reasons that aren’t well understood - an earlier viral infection can set the host up for a more serious infection when exposed at a later date to a similar virus.

 

The classic example is with Dengue (DENV), which comes in four flavors (serotypes) – and which typically produces a mild illness with the first infection, regardless of which serotype is acquired.

 

The problem usually comes later, when a person is infected with a different serotype.

 

They often (but not always) experience a more severe illness, which can even progress into DHF (Dengue Hemorrhagic Fever).

 

The prevailing theory is that the host’s immune system - which already has neutralizing antibodies to the first DENV infection - mistakenly identifies the second DENV infection as being the same strain.

 

Rather than creating new neutralizing antibodies to fight the infection, it deploys its existing cross reactive, but non-neutralizing (read: ineffective) antibodies to the field of battle.


Sometimes called OAS or Original Antigenic Sin, this is the immunological equivalent of taking a knife to a gun fight.

 

Original Antigenic Sin was coined in 1960 by Thomas Francis, Jr. in the article On the Doctrine of Original Antigenic Sin) that postulates that when the body’s immune system is exposed to and develops an immunological memory to one virus, it may be less able to mount a defense against a subsequent exposure to a second slightly different version of the virus.

OAS has been described in relation to influenza viruses, Dengue Fever, and HIV. You can find a terrific background piece on OAS from 2009 by Robert Roos in my blog entitled CIDRAP On Original Antigenic Sin.

 

And if mistakenly sending the wrong antibodies into the fray isn’t bad enough, sometimes non-neutralizing antibodies can actually enhance a virus’s ability to enter a host’s cells via a process called ADE or Antibody-dependent enhancement.

 

The result can be either an increased susceptibility to infection, a more severe course of illness, or both.

 

In this paper, the authors are suggesting that researchers look beyond simple socio-cultural behaviors to explain the age shift with H7N9, and consider what potential immunological effects that decades of exposures to a variety of influenza viruses might be having on an older population.

 

It is, as they say, complicated.  And not without controversy.

 

For more on this fascinating, but unresolved `Canadian problem’ - which the authors suggest may have some bearing on the epidemiology of H7N9 - you may wish to revisit:

 

ICAAC: Ferreting Out The `Canadian Problem’

 

EID Journal: Revisiting The `Canadian Problem’

 

Flu Vaccines & The Temporary Immunity Hypothesis

Monday, March 07, 2011

Flu Vaccines & The Temporary Immunity Hypothesis

 

 

# 5359

 

 

Late last week several Australian newspapers carried press reports on concerns expressed by Peter Collignon, a Professor of Infectious Diseases and Microbiology at the Australian National University, on the possibility that getting the seasonal flu shot may have increased the likelihood of contracting the 2009 pandemic strain.

 

Coverage included:

 

Rethink flu vaccine policy, says health expert

Adam Cresswell,

Health Editor From: The Australian March 04, 2011

 

Vaccines may have increased swine flu risk

By Annie Guest: ABC News

 

As you might imagine, these claims have sparked considerable concern and controversy. 

 

Although all of the facts are not in, and the data is – at bestcontradictory, this morning I thought we’d take a look at Professor Collignon’s concerns.

 

Ironically, after years of hearing from critics that flu vaccines are ineffective, the problem may be that the seasonal flu vaccine worked too well.

 


First a bit of background.  Regular readers will be somewhat familiar with the following:

 

In the fall of 2009, news of an unpublished Canadian study began to surface that suggested that those who had received a seasonal flu shot the previous year were more likely to contract the new pandemic virus than those who hadn’t.

 

Helen Branswell, science and medical reporter for the Canadian Press, was among the first to report on it (see Branswell On The Canadian Flu Shot Controversy).

 

With many Canadian provinces just days away from starting up their seasonal flu vaccination campaigns while they awaited the arrival of the pandemic vaccine later in the fall, this was a bombshell.

 

Suddenly, there was genuine concern that maybe  . . .  just maybe  . . .  with a pandemic virus on the way, that rolling out the seasonal vaccine was the wrong thing to do. 

 

 

The CDC and the World Health Organization both looked at their data, and issued statements that they could find no correlation between the seasonal vaccination and increased susceptibility to the pandemic flu . . . but that they would continue to look.

 

Meanwhile, with concerns rising, a number of Canadian Provinces halted or announced delays in rolling out the seasonal flu shot, even though the study had yet to be published (see Ontario Adjusts Vaccination Plan).

 

October saw a number of new reports and studies that failed to support the `Canadian problem’, including a study published in the BMJ (British Medical Journal) that suggested exactly the opposite.

 

It postulated that getting the seasonal flu vaccination may have been slightly protective against the swine flu  (see When Studies Collide).

 

This, admittedly, ran contrary to what we’d heard from the CDC, who maintained that the seasonal vaccine was not expected to offer any protection against the novel H1N1 swine flu virus.

 

By November, with no further evidence of the `Canadian Problem’, Canada’s National Advisory Committee on Immunization (NACI) came out in favor of resuming seasonal flu jabs (see NACI: Canada Should Resume Seasonal Flu Vaccinations).

 

The controversy didn’t go away, however.

 

In April of 2010 the Canadian study was finally published by PLoS Medicine. Writing for CIDRAP, Maryn McKenna   detailed their findings.

 

New Canadian studies suggest seasonal flu shot increased H1N1 risk

Maryn McKenna * Contributing Writer

Apr 6, 2010 (CIDRAP News) – Despite a rapidly launched range of studies, investigators in Canada are still unable to say—or to rule out—whether receiving a seasonal flu vaccination in the 2008-09 season made it more likely that Canadians would become ill from 2009 pandemic H1N1 flu.

(Continue . . .)

 

 

Other studies, however, failed to show any correlation, leaving us with a bit of a mystery on our hands. 

 

In November of last year, an article appeared in the Eurosurveillance Journal that suggested that contracting seasonal flu (as opposed to being vaccinated against it) temporarily ramped up the body’s immune system against other viruses – and that this protective effect could last months.

 

Eurosurveillance, Volume 15, Issue 47, 25 November 2010

Perspectives

Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection

H Kelly , S Barry, K Laurie, G Mercer

 

Unlike the Canadian researchers, Australian scientists could find no increased susceptibility to the pandemic H1N1 virus among those who had been vaccinated the previous year against seasonal flu.

 

The difference between the two findings, they suggest, comes from three separate factors:

 

  • A theory regarding temporary immunity following any influenza infection
  • The timing of the arrival of the pandemic virus in Canada
  • And the protective effects of seasonal flu vaccination against seasonal - but not pandemic - flu.

 

In Canada, the first wave of the virus arrived on the heels of the 2008-2009 seasonal flu epidemic, which had peaked only 3 months earlier. Australia, however, was nearing the end of their summer, and the peak of their flu season had occurred a full 9 months before.

 

If the temporary immunity theory was correct (`if’ being the operative word), Canadians who had contracted seasonal flu earlier in the year, might still have carried some generic immunity against infection.

 

Australians, on the other hand, saw the pandemic virus arrive long after any such temporary protective benefits would have decayed.

 

This temporary immunity – which some scientists believe may be a linked to the theory of OAS (Original Antigenic Sin) – is not well understood.  Complex, and deserving of a blog of its own, I won’t go into detail on OAS today, since we’ve discussed it before:

 

EID Journal: Original Antigenic Sin And Pandemic H1N1

 

CIDRAP On Original Antigenic Sin

 

 

In December of 2010, in the journal Clinical Infectious Diseases, we saw another study – this time in Hong Kong – that looked at the potential interaction between the 2008 seasonal vaccine, influenza infection, and the 2009 pandemic flu.

 

Protective Efficacy of Seasonal Influenza Vaccination against Seasonal and Pandemic Influenza Virus Infection during 2009 in Hong Kong

Benjamin J. Cowling,Sophia Ng, Edward S. K. Ma, Calvin K. Y. Cheng, Winnie Wai, Vicky J. Fang, Kwok-Hung Chan, Dennis K. M. Ip, Susan S. Chiu,  J. S. Malik Peiris and Gabriel M. Leung

Conclusions. TIV protected against strain-matched infection in children. Seasonal influenza infection appeared to confer cross-protection against pandemic influenza. Whether prior seasonal influenza vaccination affects the risk of infection with the pandemic strain requires additional study.

 

Once again, evidence to suggest that catching the seasonal flu during the winter of 2008-2009 was somewhat protective against contracting the pandemic in the months following.

 

Which brings us back to Professor Collignon, who is suggesting that we should reassess our vaccination policies.

 

He argues that it may be better for healthy adults to get the seasonal flu – and develop more robust temporary immunity against potentially emerging viruses – than to routinely get the flu jab.

 

This is a controversial stance, and one that is not widely shared by researchers, scientists, and public health officials.  

 

Arguing for the seasonal flu vaccine are that even healthy adults can suffer serious illness from influenza, and that any broad viral immunity from contracting seasonal flu is likely short-lived – probably measured in months, not in years.

 

When you add the fact that novel (pandemic) viruses emerge infrequently, the case for getting the annual flu shot grows stronger.  

 

For now, the Temporary Immunity Hypothesis remains an intriguing, but as-yet unproven theory.

 

For those who like their science neat and tidy, devoid of ambiguity, and rock solid . . .  all of this is no doubt a bit disconcerting. But this is how scientific progress works.

 

Slowly, deliberately, and not always advancing in a linear fashion. Simply put, good science takes time.

 

While I find all this quite thought provoking - and absolute truths are always elusive - unless and until more compelling data to the contrary comes forth, I intend to get my flu shot every year.

 

Call it a calculated risk.

 

After all . . .  a pandemic may occur once every couple of decades, but seasonal flu comes around every year.

Saturday, May 29, 2010

EID Journal: Original Antigenic Sin And Pandemic H1N1

 

 

# 4506

 

 

For those who like their science neat and tidy, devoid of ambiguity, and rock solid . . . the following will prove less than satisfying; a discussion of OAS, or Original Antigenic Sin in this month’s EID Journal  along with some valuable analysis by CIDRAP News

 

While fascinating, there are far more questions than answers at this point.  

 

Original Antigenic Sin is a term coined in 1960 by Thomas Francis, Jr. in the article On the Doctrine of Original Antigenic Sin) that postulates that when the body’s immune system is exposed to and develops an immunological memory to one virus, it may be less able to mount a defense against a subsequent exposure to a second slightly different version of the virus.

Original Antigenic sin has been described in relation to influenza viruses, Dengue Fever, and HIV.  You can find a terrific background piece on OAS from last year by Robert Roos in my blog entitled CIDRAP On Original Antigenic Sin

 

 

In the most recent edition of the EID Journal we get a letter suggesting OAS as an explanation for the age shift to a younger demographic we saw with novel H1N1, along with a separate commentary.

 

Admittedly these are confusing, often technical discussions, cloaked in more than a little uncertainty. Luckily Robert Roos, Editor of CIDRAP News, has once again stepped up with an excellent summary of this difficult concept to help us along.

 

No  . . . you won’t find any definitive answers here, but you will find some intriguing questions.

 

 

Volume 16, Number 6–June 2010
Letter

Original Antigenic Sin and Pandemic (H1N1) 2009

Amesh A. Adalja Comments to 
Author and D.A. Henderson
Author affiliations: University of Pittsburgh Medical Center, Baltimore, Maryland, USA

 

To the Editor: While pandemic (H1N1) 2009 was in its earliest stages, age distribution data indicated surprisingly few cases among persons >65 years of age. The initial assumption was that few persons >65 years of age had yet to be exposed. However, as more data became available from Mexico, Australia, and the United States, the age distribution pattern persisted (1).

This observation raised the question about whether older persons were protected from infection with an influenza virus A (H1N1) strain acquired many years ago. Indeed, data from the Centers for Disease Control and Prevention showed that approximately two thirds of older persons have evidence of immunity to pandemic (H1N1) 2009 virus. In 1960, Thomas Francis proposed the hypothesis of original antigenic sin, a phenomenon whereby a person who as a child was first exposed to a specific influenza virus A would, throughout life, mount an immune response to the virus of childhood, even when exposed to other antigenically dissimilar influenza viruses. In effect, the original antibody response generated by the immune system against a specific influenza viral strain was hypothesized to have colored all future responses to influenza (2).

(Continue . . . )

 

 

 

Volume 16, Number 6–June 2010
Commentary

The Wages of Original Antigenic Sin

David M. Morens, Comments to 
Author Donald S. Burke, and Scott B. Halstead

What epidemiologist Thomas Francis, Jr. (1900–1969) was thinking when pondering certain inexplicable serologic data from a 1946 influenza vaccine trial may never be known. Whether in religious reverence for the beauty of science or impish delight fueled by the martini breaks of which he was so fond, Francis coined the term "original antigenic sin" to describe a curious new immunologic phenomenon. Elsewhere in this issue, Adalja and Henderson propose that original antigenic sin has altered the population age–specific incidence of infection and disease caused by influenza A pandemic (H1N1) 2009 virus and that public health responses must account for the disruption (1). What is original antigenic sin, what is its immunologic basis, and into what sort of trouble is it getting us?

(Continue . . . )

 

 

Confused yet?   Robert Roos of CIDRAP may not have the answers, but he does organize and explain the questions exceedingly well.  Highly recommended.

 

 

Age profile of H1N1 cases sparks discussion of 'original antigenic sin'

Robert Roos * News Editor

May 28, 2010 (CIDRAP News) – A letter and commentary published this week in Emerging Infectious Diseases explore the idea that "original antigenic sin"—the hypothesis that the first influenza A virus a person encounters in childhood strongly influences his or her immune responses to all related flu viruses encountered later—may explain the partial protection that older people have against the pandemic H1N1 flu virus.

 

As explained in the letter by Amesh A. Adalja and D. A. Henderson of the University of Pittsburgh Medical Center, original antigenic sin (OAS) holds that a person who is exposed to an influenza A virus in childhood will, in later encounters with related flu viruses, mount an immune response primarily directed at the original virus, even when the newly encountered virus is antigenically different. An implication of the theory is that OAS can trigger an ineffective or less effective immune response when a person is exposed to a virus that's related to the original one.

 

Because H1N1 viruses circulated continually from 1918 until 1957, most people born before 1957 were exposed to them, Adalja and Henderson write. "According to the theory of original sin, these persons may have partial protection from severe disease from infection with the new influenza virus A (H1N1)," they state.

 

The accompanying commentary, written by three other experts, generally concurs that OAS may account for the protection older people enjoy but says it is unclear whether the phenomenon is a bane or a blessing overall.

 

Meanwhile, another virology expert told CIDRAP News that there is conflicting evidence on OAS and that it may not be necessary to invoke such a complex idea to explain older people's immunity to the pandemic virus.

(Continue . . .)